COMMUNIQUÉS West-GlobeNewswire

Emergent BioSolutions to Release Fourth Quarter and Full Year 2018 Financial Results and Conduct a Conference Call on February 21, 2019

07/02/2019 - 15:35

GAITHERSBURG, Md., Feb. 07, 2019 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) will host a conference call on Thursday, February 21, 2019 at 5:00 pm (Eastern Time) to discuss the financial results for the [...]

Coherus BioSciences Announces New Employment Inducement Grants

07/02/2019 - 15:30

REDWOOD CITY, Calif., Feb. 07, 2019 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (Nasdaq: CHRS), today announced that effective February 6, 2019, the compensation committee of the company’s board of directors granted [...]

Vystar to Resume Production of Rx3000 UV Light Air Purifiers for Use in Hospitals, Healthcare Facilities

07/02/2019 - 15:18

Destroys on first pass more than 99.97% of harmful airborne viruses and bacteria. Inactivates pathogens that cause measles, the common cold, MRSA (staph), whooping cough, TB, pneumonia and other antibiotic-resistant and [...]

BioAegis Therapeutics Expands Phase 1b/2a Community-Acquired Pneumonia Study to the Republic of Georgia —Successfully Completes Second of Four Dosing Cohorts

07/02/2019 - 15:17

MORRISTOWN, N.J., Feb. 07, 2019 (GLOBE NEWSWIRE) -- BioAegis Therapeutics Inc. announced that patient enrollment is underway in a Phase 1b/2a study of recombinant plasma gelsolin (rhu-pGSN) in Community-Acquired [...]

Nemaura Medical Announces Grant of U.S. Patent for SugarBEAT® Glucose Sensing Algorithm

07/02/2019 - 15:00

Loughborough, England – February 7, 2019 – Nemaura Medical Inc. (NASDAQ: NMRD) nemauramedical.com , a medical technology company focused on the development of SugarBEAT® as a non-invasive, affordable and flexible [...]

Third Study Verifies Milestone Scientific’s CompuFlo® Instrument Differentiates False Loss of Resistance During Epidural Blocks

07/02/2019 - 15:00

Easier, more reliable identification essential to reducing failed epidurals and complications LIVINGSTON, N.J., Feb. 07, 2019 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS) today announced a new 120-patient [...]

NewLink Genetics to Host Its Fourth Quarter and Full Year 2018 Financial Results Conference Call on February 27, 2019

07/02/2019 - 15:00

AMES, Iowa, Feb. 07, 2019 (GLOBE NEWSWIRE) -- NewLink Genetics Corporation (NASDAQ:NLNK) today announced that it will release its fourth quarter and full year 2018 financial results on Wednesday, February 27, 2019. The [...]

Fluidigm Announces Co-Marketing Agreement with Indica Labs to Offer Platform for Imaging Mass Cytometry Data Analysis to Aid Novel Digital Pathology Investigations

07/02/2019 - 15:00

SOUTH SAN FRANCISCO, Calif., Feb. 07, 2019 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ: FLDM) and Indica Labs, Inc., today announced a co-marketing relationship for scalable and simple-to-use tissue image analysis [...]

Devimistat (CPI-613®) to be Explored in a New Combination for T-Cell Lymphoma Treatment as Part of Stand Up To Cancer’s T-Cell Lymphoma “Dream Team Research Grant”

07/02/2019 - 14:55

This study will be conducted under the ‘Tailoring CAR-based immunotherapy strategies to T-Cell Lymphoma’ project Newark, NJ, Feb. 07, 2019 (GLOBE NEWSWIRE) -- Rafael Pharmaceuticals, Inc. (“Rafael” or the “Company”), a [...]

Precision Therapeutics’ Skyline Medical Division Expands Presence in Australia with Three New STREAMWAY Systems at Wangaratta Hospital in Victoria

07/02/2019 - 14:45

MINNEAPOLIS, Feb. 07, 2019 (GLOBE NEWSWIRE) -- Precision Therapeutics Inc. (NASDAQ: AIPT) (“Precision” or “the Company”) today announces its Skyline Medical division, producer of the FDA-approved and CE-marked STREAMWAY [...]

Innovate Biopharmaceuticals Announces Presentation at BIO CEO & Investor Conference

07/02/2019 - 14:34

Presentation will Highlight Progress in Celiac Disease Phase 3 Trial Timeline and NASH RALEIGH, N.C., Feb. 07, 2019 (GLOBE NEWSWIRE) -- Innovate Biopharmaceuticals, Inc. (Nasdaq: INNT) a clinical stage biotechnology [...]

Fluidigm Announces Participation in Life Science/Pharma and Academic Consortium to Study T Cell-Driven Immune-Mediated Inflammatory Diseases

07/02/2019 - 14:30

Gaining insights into inflammatory bowel disease through mass cytometry and Imaging Mass Cytometry analysis of the human mucosal immune system Research aimed at more precise treatments for IMIDs using existing therapies [...]

Aleafia Health Helps Patients & Investors with Revenue Generating Research -- CFN Media

07/02/2019 - 14:30

SEATTLE, Wash., Feb. 07, 2019 (GLOBE NEWSWIRE) -- -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces [...]

Uptick Newswire Hosts Digipath, Inc. on the Stock Day Podcast to Discuss Their Increasing Revenues and the Launch of GroSciences

07/02/2019 - 14:30

PHOENIX, Feb. 07, 2019 (GLOBE NEWSWIRE) -- Uptick Newswire Stock Day Podcast welcomed Digipath, Inc. (DIGP), a service-oriented independent testing laboratory, data and media firm focused on the developing cannabis and [...]

Auxly Announces Termination of FSD Pharma Joint Venture

07/02/2019 - 14:30

VANCOUVER, British Columbia, Feb. 07, 2019 (GLOBE NEWSWIRE) -- Auxly Cannabis Group Inc. (TSX.V - XLY) (" Auxly " or the " Company ") today announced the termination of the definitive agreement dated March 3, 2018 (the [...]

Equillium Granted U.S. FDA Orphan Drug Designations for EQ001 (itolizumab) for both the Prevention and Treatment of Acute Graft-Versus-Host Disease

07/02/2019 - 14:08

LA JOLLA, Calif., Feb. 07, 2019 (GLOBE NEWSWIRE) -- Equillium, Inc. (Nasdaq: EQ), a biotechnology company developing treatments for severe immuno-inflammatory disorders, today announced that the U.S. Food and Drug [...]

Momenta Pharmaceuticals Announces Oral Presentation of New Data for M281 at the Society for Maternal-Fetal Medicine 2019 Annual Meeting

07/02/2019 - 14:00

Study highlights ability of M281 to inhibit transfer of immunoglobulin G from maternal to fetal circulation in ex vivo placental perfusion model M281 currently being evaluated in an international Phase 2 study in [...]

Evelo Biosciences to Report Fourth Quarter and Full Year 2018 Financial Results on Thursday, February 14, 2019

07/02/2019 - 14:00

CAMBRIDGE, Mass., Feb. 07, 2019 (GLOBE NEWSWIRE) -- Evelo Biosciences, Inc. (Nasdaq: EVLO) (“Evelo”), a clinical stage biotechnology company developing monoclonal microbials, a potential new modality of oral biologic [...]

Forty Seven Inc. to Present at Guggenheim Healthcare Talks Idea Forum | Oncology Day

07/02/2019 - 14:00

MENLO PARK, Calif. , Feb. 07, 2019 (GLOBE NEWSWIRE) -- Forty Seven Inc. (NASDAQ:FTSV), a clinical-stage, immuno-oncology company focused on developing therapies to activate macrophages in the fight against cancer, today [...]